Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Personalized Vaginal Microbiome Contributions to HPV-driven Pre-malignant and Malignant Cervical Cancer

NCT05640700 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT05640700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05640700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Personalized Vaginal Microbiome Contributions to HPV-driven Pre-malignant and Malignant Cervical Cancer
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Recruiting
Start date
November 9, 2022
Completion date
December 30, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer cervix uterus, cervical dysplasia, human papilloma virus, vaginal flora imbalance